It has paid a quarterly dividend consistently since 2008 and has raised it every year for the past four years.
Minnesota-based Techne derives more than 95% of its revenues from biologics products that are developed and manufactured in-house through two subsidiaries, Research and Diagnostic Systems in Minneapolis and R&D Systems Europe, which is based in Abingdon, England.
The most recent dividend payment equates to a $1.20-per-share annual dividend yielding 1.9% based on the close price of Techne's stock on April 29.
Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool recommends Techne. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.